FDA Approves Gene Therapies for Sickle Cell Disease

Two cell-based gene therapies will address the debilitating hereditary blood disorder. The U.S. Food and Drug Administration (FDA) has granted approval of two groundbreaking cell-based gene therapies, Casgevy…

Read More

FDA Approves New Treatment for Rare Blood Clotting Disorder

Director Marks announced the therapy for the life-threatening disorder. The U.S. Food and Drug Administration recently approved Adzynma for patients with congenital thrombotic thrombocytopenic purpura (cTTP). The genetically…

Read More

FDA Warns of Probiotic Risks for Preterm Infants

The agency encourages reporting of illegally marketed substances. The U.S. Food and Drug Administration (FDA) has issued a warning for the public and healthcare providers regarding the risks…

Read More

FDA Approves Cell Therapy for Blood Cancer Patients

Cell therapy has the potential to reduce the risk of infection after stem cell transplants. The U.S. Food and Drug Administration (FDA) recently approved Omisirge (omidubicel-onlv), a donor-modified…

Read More
Back to top
FE3